Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06911723 · ClinicalTrials.gov registry record · NA
Activities to Change Your Mood: A Test of the Acceptability and Initial Efficacy in Clinical Samples and Healthy Controls
A NA study of Schizophrenia Disorders, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06911723: Recruiting NA study of Schizophrenia Disorders, sponsored by University of Alabama at Birmingham.
NCT06911723 is a NA study of Schizophrenia Disorders that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 200 participants, above the 100-participant average among 5 other Schizophrenia Disorders trials with a reported enrollment target (100% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06911723, a NA study of Schizophrenia Disorders, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study investigating how brief online activities can influence mood and attitudes.
Primary Outcome
Depression measure
Conditions Studied
Interventions
- BEHAVIORAL Brief Activities
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-08-20 |
| Est. Completion | 2028-12 |
| Phase | NA |
What NCT06911723 shows while recruiting
NCT06911723 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 100-participant average among 5 other Schizophrenia Disorders trials with a reported enrollment target (100% higher).
The record links to 1 condition, with Schizophrenia Disorders appearing as the primary indexed condition, and to 1 intervention - of which Brief Activities is the first listed.
NCT06911723 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT06911723 about?
NCT06911723 is a clinical study titled "Activities to Change Your Mood: A Test of the Acceptability and Initial Efficacy in Clinical Samples and Healthy Controls". This is a study investigating how brief online activities can influence mood and attitudes.
What is the current status of trial NCT06911723?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-08-20. Estimated completion is 2028-12.
What conditions does trial NCT06911723 study?
This clinical trial studies the following conditions: Schizophrenia Disorders.
What interventions are being tested in trial NCT06911723?
The interventions under investigation include: Brief Activities (BEHAVIORAL).
Who is sponsoring clinical trial NCT06911723?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06911723 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy
RECRUITING · NA
-
Visual Perception in Schizophrenia
RECRUITING · NA
-
Brain Stimulation to the Hippocampus in Schizophrenia
RECRUITING · NA
-
Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
RECRUITING · NA
-
White Matter Plasticity in Schizophrenia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI